This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cell Therapeutics, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Luca Feliciotti
Introduction
Luca Feliciotti is an accomplished inventor based in Sesto San Giovanni, Italy. He has made significant contributions to the field of polymer chemistry, particularly in the preparation of poly-α-glutamic acid and its derivatives. His innovative approach has garnered attention in both academic and industrial circles.
Latest Patents
Luca Feliciotti holds a patent for a process for the preparation of poly-α-glutamic acid and derivatives thereof. This invention relates to an improved method for synthesizing poly-α-glutamic acids through the polymerization of tertiary γ-esters of α-glutamic acid N-carboxy anhydride. The process utilizes appropriate solvents and initiators, followed by acid hydrolysis of the resulting poly-α-glutamic acid-γ-ester. This method is particularly advantageous as it allows for precise control over the molecular weight of the resulting poly-α-glutamic acid.
Career Highlights
Throughout his career, Luca has worked with notable companies such as Cell Therapeutics, Inc. and its secondary office, Cell Therapeutics, Inc. - Sede Secondaria. His work in these organizations has contributed to advancements in therapeutic applications of polymers.
Collaborations
Luca has collaborated with esteemed colleagues, including Marc J. McKennon and Giovanni Da Re. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Luca Feliciotti's contributions to the field of polymer chemistry, particularly through his patent on poly-α-glutamic acid, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the development of new materials and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile